To reach the next value inflection
LicenseRx asset brief
Protein Sequences for Therapeutic Applications in Management of Obesity, Cachexia and Nausea
Probability of Success
24% · grade C · Medium data confidence
Model PoS 24% (grade C, medium data confidence). Strongest signals: Data maturity, IP position. Biggest drag: Translational evidence.
Data maturity (22%)
54
Preclinical; limited public evidence of validation.
IP position (16%)
72
Patent filed/pending -- prosecution ongoing.
Modality feasibility (14%)
66
Biologic/antibody -- solid path but higher CMC burden.
Indication pull (14%)
77
Oncology, Neurology -- active buyer appetite.
Competitive whitespace (12%)
66
Crowded oncology field; multi-modal differentiation.
Translational evidence (12%)
46
No translational evidence keywords in the public summary -- lab-stage claim.
Licensing readiness (10%)
94
Listed as available for licensing; established tech-transfer office; 1 public source link(s).
Unlock the full strategic deep dive
Cost to the next milestone, decisive data, relevant articles, and the partner-ready development plan for this asset.
View Operator access See what's included →